Participated · Series B · Apr 2022

ProofPilot provides StudyCoPilot, a clinical experience platform that centralizes and simplifies communication for sponsors, patients, and sites across the clinical trial experience. Its products and services support initiatives such as improving DE&I, streamlining recruitment and retention, and easing site burden. The system has scaled capabilities for enterprise use and has pharmaceutical clients deploying it globally. The company raised a Series C and intends to use the funds to expand operations and broaden its business reach. CEO Chris Venezia said repeat investment from Series B investors validates market need and provides resources to scale and accelerate life-saving therapies. ProofPilot is a NYC-based Software as a Service clinical trial research platform that enables users to design, launch, participate in, and manage research studies. The company provides a fully digitized platform with self-design study tools, trial process management, and remote source verification capabilities. It offers two products: ProofPilot Rx for life science companies and ProofPilot 365 for wellness interventions. ProofPilot was founded in 2014 by Matthew Amsden. The company raised over $12M in a Series B financing announced April 4, 2022. As part of the raise, investor and healthcare strategist Esther Dyson joined ProofPilot’s board of directors. ProofPilot is a New York-based startup that helps researchers design and manage scientific studies, including randomized controlled trials and outcome studies. Its platform aims to reduce systematic issues that arise during study execution and to make research more efficient. The company launched after receiving $1.85 million in investment from CueBall Capital, Brooklyn Bridge Ventures and others. Cofounder Matthew Amsden said ProofPilot was born from frustration that health and social innovations were getting lost because it was too expensive to test whether they worked. The company raised the capital in 2014, then took a brief break to further develop its technology. It has now returned with the goal of allowing researchers' work to be guided by curiosity rather than concerns about protocol. ProofPilot aims to make it easier and more efficient for professionals to run studies.